Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.49 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TNF | P01375 | 2/20 | 0.47 |
| ▸ | NOD2 | Q9HC29 | 2/20 | 0.47 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.47 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2956007 | 0.98 | NOS2 (0.96) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL8395946 | 0.76 | NOS2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL9187589 | 0.76 | NOS2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL5144258 | 0.76 | NOS2 (0.61) | NOS2HTTNPC1RAB9APOLB | |
| SCHEMBL23038778 | 0.76 | NOS2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL30621933 | 0.76 | SMN1; SMN2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL22248139 | 0.76 | NOS2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL149707 | 0.76 | SMN1; SMN2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL18634230 | 0.76 | NOS2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 | |
| SCHEMBL28125888 | 0.76 | NOS2 (0.61) | NOS2CYP1A2CYP2D6HTTCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119736730-A | Purple-black polyimide fiber and preparation method and application thereof | 江苏先诺新材料科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119709104-A | Synthesis method of high-performance polyimide binder with three-dimensional reticular structure | 江西洪州职业学院 | 2025-03-28 | — | — | CN | claimed |
| CN-119074684-A | Drug delivery nano vesicle based on self-activated T cell membrane, preparation method and application | 重庆医科大学附属第一医院 | 2024-12-06 | — | — | CN | claimed |
| CN-119061510-A | Polyimide heat-insulating nanofiber with controllable cavity structure and preparation method and application thereof | 陕西科技大学 | 2024-12-03 | — | — | CN | claimed |
| CN-119060537-A | Self-lubricating wear-resistant polyphenylene sulfide-based composite material and preparation method thereof | 江西聚真科技发展有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118873559-A | Macrophage-oncolytic virus coupling system, preparation method and application thereof in preparing antitumor drugs | 国科温州研究院(温州生物材料与工程研究所) | 2024-11-01 | — | — | CN | claimed |
| CN-118122270-A | Composite aerogel of bimetal ZIF and biomass charcoal, and preparation method and application thereof | 重庆大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117250833-A | Semiconductor chip photoresist cleaning solution, preparation method and application thereof | 浙江奥首材料科技有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-116965422-A | Permanent antibacterial microcapsule composite material and preparation method thereof | 江苏海洋大学 | 2023-10-31 | — | — | CN | claimed |
| US-20070065443-A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | DYNAMIS THERAPEUTICS, INC. | 2007-03-22 | — | — | US | claimed |
| EP-1753861-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | Dynamis Therapeutics, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| WO-2005079463-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | DYNAMIS THERAPEUTICS, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | DYNAMIS THERAPEUTICS, INC. | 2005-07-21 | — | — | US | claimed |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS, INC. | 2003-11-27 | — | — | US | claimed |
| EP-0669380-B1 | Process for the preparation of azo dyes | CIBA SC HOLDING AG (CH) | 2001-03-28 | — | — | EP | claimed |
| US-5326779-A | Method of inhibiting the advanced glycosylation of proteins using 1,2-disubstituted-benzimidazoles | THE ROCKEFELLER UNIVERSITY (US) | 1994-07-05 | — | — | US | claimed |
| CN-121375239-A | Flame-retardant heat-insulation aluminum foil rib-sandwiched composite material and preparation method thereof | 无锡奇安特保温材料有限公司 | 2026-01-23 | — | — | CN | disclosed |
| EP-4373811-A4 | NOVEL 1,2-DIAMINOBENZIMIDAZOLE DERIVATIVE | Carna Biosciences, Inc. (JP) | 2025-05-21 | — | — | EP | disclosed |
| EP-0001246-A1 | Preparation of 2-(3'- or 4'-aminophenyl)-5(or 6)-aminobenzimidazoles | CASSELLA Aktiengesellschaft (DE) | 1979-04-04 | — | — | EP | disclosed |
| US-4000135-A | IRON TETRAAZANNULENES AS CATALYSTS | BASF AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070065443-A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | FN3K, PDXK, COLGALT1 | NOS2 2809/4885CYP1A2 3833/4885CYP2D6 4398/4885 |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DPM1, G6PD, UGGT1 | NOS2 2855/4885CYP1A2 1388/4885CYP2D6 551/4885 |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | AGER, GLA, GALE | NOS2 1372/4885CYP1A2 1462/4885CYP2D6 862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.